Narcan vending machine opens at convenience store in Midtown Nashville
NASHVILLE, Tenn. (WKRN) — A Twice Daily convenience store in Midtown Nashville has become the first of its kind to provide free opioid overdose reversal medication to the community.
In an initiative led by Fund Recovery, a vending machine stocked with Narcan — a brand name of the medication Naloxone — was installed outside the store Tuesday.
Man wanted after stabbing wife to death at Madison elementary school, police say
The store, located at 1702 West End Avenue, held a ribbon-cutting event to celebrate the project.
In early March, the organization installed three Naloxone vending machines in Fentress County. According to Fund Recovery, Nashville was chosen as another ideal location for the machines because of the number of fatal overdoses that occur in Davidson County.
'We are essentially taking Naloxone vending machines in different strategic locations around the country where there is a high rate of overdose deaths and we're partnering with local resources, so here in Metro Nashville, we partner with Metro Department of Public Health as well as the Tennessee REDLINE, so when this medicine is deployed, we have local resources to connect them with,' said Ryan Cain, Fund Recovery board chair.
⏩
Titans defensive tackle Jeffery Simmons attended the ribbon-cutting. He has worked with Fund Recovery to promote Naloxone awareness through the 'Tackle Overdoses Now' campaign.
Naloxone vending machines are also available at two Davidson County Sheriff's Office facilities: at the Downtown Detention Center on James Robertson Parkway and its Harding Place facility.
If you or someone you know is struggling with addiction, the Tennessee REDLINE is a FREE service that provides accurate, up-to-date addiction information and referrals to anyone 24 hours a day, seven days a week. Call 1-800-889-9789 toll-free or visit the Tennessee REDLINE website here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
McKee signs four pairs of bills into law
Automatic external defibrillators will now be required on golf courses as a result of a new law named for a Johnston golfer who died after having a heart attack on the 18th hole at the Cranston Country Club in 2023. (Getty image) Four new laws signed on June 6 by Gov. Dan McKee aim to improve emergency care for heart attacks on golf courses, train lifeguards and park rangers to administer Narcan, extend the trial period for the state's safe injection site in Providence, and formalize the waiting period before adults with drivers permits can take their road test. Here's a look at the legislation behind the four new laws: 1. Automatic external defibrillators will now be required on golf courses as a result of the David Casey Act. Its namesake is a Johnston golfer who died after having a heart attack on the 18th hole at the Cranston Country Club. Casey was 58 years old. Companion bills, sponsored by Rep. Deborah Fellela and Sen. Andrew Dimitiri, both Johnston Democrats, amended the state's rules on locations where defibrillators are mandatory. State law had required defibrillators in enclosed spaces capable of holding 300 or more people. Spaces include bars, self-service laundry, shopping malls, arenas, government offices, and waiting rooms. 'David's death was tragic, and has mobilized his widow, Betsy, to become an advocate for AEDs on all golf courses,' Felella said in a statement issued by the State House Tuesday. 'She wants to make sure that David's death makes a difference, and if we save even one life, we reach that goal.' Rhode Island Department of Health Director Jerome 'Jerry' Larkin voiced support for the legislation in a Feb. 6 letter to the House Committee on Health and Human Services. He stated that using defibrillators and performing CPR within minutes of cardiac arrest can significantly boost survival rates. 2. The nation's first state-regulated safe injection site will continue for another two years. Project Weber/RENEW, the nonprofit that operates the South Providence site at 45 Willard Ave., was supposed to end its pilot overdose prevention program in 2026. Legislation sponsored by Rep. Jay Edwards, a Tiverton Democrat, extends the program through 2028. The law also mandates new reporting requirements on the number of people connected to other specialists for addiction treatment, and total overdoses prevented. McKee, Providence Mayor Brett Smiley and the Mental Health Association of Rhode Island each wrote to lawmakers to back the extension bill. 'Even one more life lost to substance use disorder and the opioid epidemic is one too many and HRCs are a critical preventative resource,' McKee wrote to the committee in February. Companion legislation was sponsored in the Senate by Sen. Melissa Murray, a Woonsocket Democrat. 3. Rhode Island's lifeguards and park rangers will now be required to be trained in administering opioid reversal drugs such as Narcan. This mandate comes from companion bills sponsored by Rep. William O'Brien, a North Providence Democrat, and Senate Majority Whip David Tikoian, a Smithfield Democrat. The bill also requires public beaches and parks to have at least four doses of this medicine available at all times. 'The sad reality we find ourselves in today is that opioid overdoses can happen anytime and anywhere,' O'Brien said in a statement. 'While we continue to combat the opioid crisis, this bill will save many lives.' The legislation originated from North Providence High School student Brennan O'Connor's senior project, according to a State House news release. 4. Rhode Island residents age 18 or older will have to wait at least 30 days after receiving a learner's permit before taking the road test. The law signed by McKee stems from matching bills sponsored by Democrats Rep. Robert Phillips of Woonsocket and Sen. Lou DiPalma of Middletown. It requires adults to wait at least 30 days after receiving a learner's permit before taking the road test for a full license. Rhode Island's Division of Motor Vehicles already mandates a 30-day waiting period, agency spokesperson Paul Grimaldi said via email Tuesday. It just was never codified under state law. 'A way to make certain things clear and succinct — you put it into Rhode Island General Law' DiPalma said in an interview. Under the new law, adult drivers' permits would expire one year after being issued. Permits can be renewed, but just once. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX
Yahoo
10 hours ago
- Yahoo
RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
Robert F. Kennedy Jr. testifying during his Senate Committee on Health, Education, Labor and Pensions confirmation hearing on January 30, 2025 in Washington, DC Credit - Kevin Dietsch—Getty Images When Secretary Robert F. Kennedy Jr. began his tenure as Health and Human Services Secretary, he pledged, 'We won't take away anyone's vaccines.' However, recent policy changes under his leadership—coupled with the unprecedented dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9—have proven that statement false, raising grave concerns for our nation's COVID-19 response and broader vaccine policies. These shifts not only jeopardize public health but also threaten to erode trust in our health institutions at a critical time. In May 2025, the Food and Drug Administration (FDA) introduced a new COVID-19 vaccine framework, limiting access to updated vaccines for Americans aged 65 and older or those with specific risk factors. Furthermore, Secretary Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for 'healthy' children or pregnant women—bypassing the standard ACIP review process. Compounding these changes, the abrupt removal of ACIP's entire panel of independent experts, who have guided evidence-based vaccine policy for decades, risks destabilizing a cornerstone of public health. These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems. Read More: What to Know About RFK Jr. Removing All Experts From CDC Vaccine Advisory Committee During my tenure as Surgeon General under the first Trump administration, we faced significant public health challenges, from addressing the opioid epidemic by increasing access to Naloxone to launching Operation Warp Speed for the COVID-19 vaccine development effort. The vaccines developed under Trump's first term have proven to be one of our most effective defenses against COVID-19; yet, the current administration's new policies limit their availability, potentially leaving millions vulnerable. The dismissal of ACIP's experts—without a clear plan for replacing them with qualified scientists—further jeopardizes trust in the institutions tasked with protecting Americans. The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024—more than breast cancer or car accidents. The fact is, 75% of Americans have risk factors, such as obesity or diabetes, that increase their vulnerability to severe COVID outcomes. However, the burden is now placed on individuals to self-identify as high risk, creating confusion and inconsistency in access. Unlike other countries with centralized systems for identifying at-risk individuals, the U.S. expects patients—many of whom lack easy access to healthcare—to navigate eligibility alone. Risk assessment should also consider individual circumstances beyond underlying health conditions. A 58-year-old bus driver or healthcare worker faces significantly greater exposure than someone working remotely. By limiting vaccines to specific groups based solely on preexisting health status, the policy overlooks these critical contextual differences. Secretary Kennedy's team argues that there is insufficient evidence to support updated COVID-19 vaccines for healthy Americans under 65, but this claim is flatly unfounded. Years of real-world data demonstrate that vaccines save lives and reduce hospitalizations across all age groups. During the 2023 to 2024 fall and winter season, 95% of those hospitalized for COVID had not received an updated vaccine. While the administration cites other countries' more restrictive vaccine policies, such comparisons ignore the unique health landscape in the U.S., which includes higher obesity rates, worse maternal health outcomes, and uneven healthcare access. The policy also neglects the issue of Long COVID, which affects millions with debilitating symptoms lasting months or years. Though older adults are at higher risk for severe acute infections, Long COVID disproportionately impacts adults aged 35 to 49—and children are also affected. Vaccination reduces the risk of developing Long COVID, an essential reason many healthy individuals choose to stay up-to-date with their vaccines. Read More: What's the Risk of Getting Long COVID in 2024? Particularly concerning is the decision to end COVID vaccine recommendations for 'healthy' pregnant women, which contradicts the FDA's own guidance. Pregnant women face heightened risks of severe COVID outcomes, including death, pre-eclampsia, and miscarriage. Vaccination during pregnancy is crucial—not just for maternal health but also for protecting infants under six months, who cannot be vaccinated and rely on maternal antibodies for protection. Decades of research confirm that vaccines, including COVID vaccines, safely transfer antibodies to newborns, lowering their risk of severe illness. The dismissal of ACIP's members amplifies these concerns. ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health. Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices. This move fuels vaccine hesitancy and skepticism about public health decisions, particularly when paired with the bypassing of ACIP's review process for the new COVID vaccine policies. These changes create uncertainty about who can access vaccines. Without clear CDC recommendations, insurance companies may impose their own coverage criteria, potentially increasing costs for a vaccine that was previously free for most Americans. Healthcare providers, lacking federal guidance and ACIP's expertise, may struggle to advise patients, leading to a confusing and inequitable system that limits choice—hardly the 'medical freedom' Secretary Kennedy claims to champion. Ultimately, these actions threaten to erode trust in public health. FDA officials argue the new framework enhances transparency, yet bypassing ACIP's review and dismissing its members undermines that aim. Extensive data demonstrate that updated vaccines lower hospitalization and death rates, yet this evidence was sidelined. Such actions breed skepticism, making it harder to unite Americans around shared health goals. The stakes are high, but a better path is possible. Restoring trust requires transparent, evidence-based policymaking that prioritizes access to life-saving tools. I urge Secretary Kennedy and the administration to reconsider this framework, reinstate ACIP's role in vaccine policy, and ensure any new appointees are qualified, independent experts. If concerns about ACIP exist, they should be addressed through reform, not dissolution. Healthcare providers and community leaders must also educate patients about vaccination benefits, particularly for vulnerable groups like pregnant women and those with high exposure. Individuals can take action by staying informed, discussing vaccination with their doctors, and advocating for clear, equitable access to vaccines. By working together—government, providers, and citizens—we can protect lives, reduce the burden of Long COVID, and rebuild confidence in our public health system. We must seize this opportunity to unite around science and ensure a healthier, safer, and prosperous future for all Americans. Contact us at letters@


Time Magazine
12 hours ago
- Time Magazine
Trump's First Surgeon General: RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
When Secretary Robert F. Kennedy Jr. began his tenure as Health and Human Services Secretary, he pledged, 'We won't take away anyone's vaccines.' However, recent policy changes under his leadership—coupled with the unprecedented dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) on June 9—have proven that statement false, raising grave concerns for our nation's COVID-19 response and broader vaccine policies. These shifts not only jeopardize public health but also threaten to erode trust in our health institutions at a critical time. In May 2025, the Food and Drug Administration (FDA) introduced a new COVID-19 vaccine framework, limiting access to updated vaccines for Americans aged 65 and older or those with specific risk factors. Furthermore, Secretary Kennedy announced that the Centers for Disease Control and Prevention (CDC) would no longer recommend COVID-19 vaccines for 'healthy' children or pregnant women—bypassing the standard ACIP review process. Compounding these changes, the abrupt removal of ACIP's entire panel of independent experts, who have guided evidence-based vaccine policy for decades, risks destabilizing a cornerstone of public health. These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems. During my tenure as Surgeon General under the first Trump administration, we faced significant public health challenges, from addressing the opioid epidemic by increasing access to Naloxone to launching Operation Warp Speed for the COVID-19 vaccine development effort. The vaccines developed under Trump's first term have proven to be one of our most effective defenses against COVID-19; yet, the current administration's new policies limit their availability, potentially leaving millions vulnerable. The dismissal of ACIP's experts—without a clear plan for replacing them with qualified scientists—further jeopardizes trust in the institutions tasked with protecting Americans. The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024—more than breast cancer or car accidents. The fact is, 75% of Americans have risk factors, such as obesity or diabetes, that increase their vulnerability to severe COVID outcomes. However, the burden is now placed on individuals to self-identify as high risk, creating confusion and inconsistency in access. Unlike other countries with centralized systems for identifying at-risk individuals, the U.S. expects patients—many of whom lack easy access to healthcare—to navigate eligibility alone. Risk assessment should also consider individual circumstances beyond underlying health conditions. A 58-year-old bus driver or healthcare worker faces significantly greater exposure than someone working remotely. By limiting vaccines to specific groups based solely on preexisting health status, the policy overlooks these critical contextual differences. Secretary Kennedy's team argues that there is insufficient evidence to support updated COVID-19 vaccines for healthy Americans under 65, but this claim is flatly unfounded. Years of real-world data demonstrate that vaccines save lives and reduce hospitalizations across all age groups. During the 2023 to 2024 fall and winter season, 95% of those hospitalized for COVID had not received an updated vaccine. While the administration cites other countries' more restrictive vaccine policies, such comparisons ignore the unique health landscape in the U.S., which includes higher obesity rates, worse maternal health outcomes, and uneven healthcare access. The policy also neglects the issue of Long COVID, which affects millions with debilitating symptoms lasting months or years. Though older adults are at higher risk for severe acute infections, Long COVID disproportionately impacts adults aged 35 to 49—and children are also affected. Vaccination reduces the risk of developing Long COVID, an essential reason many healthy individuals choose to stay up-to-date with their vaccines. Particularly concerning is the decision to end COVID vaccine recommendations for 'healthy' pregnant women, which contradicts the FDA's own guidance. Pregnant women face heightened risks of severe COVID outcomes, including death, pre-eclampsia, and miscarriage. Vaccination during pregnancy is crucial—not just for maternal health but also for protecting infants under six months, who cannot be vaccinated and rely on maternal antibodies for protection. Decades of research confirm that vaccines, including COVID vaccines, safely transfer antibodies to newborns, lowering their risk of severe illness. The dismissal of ACIP's members amplifies these concerns. ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health. Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices. This move fuels vaccine hesitancy and skepticism about public health decisions, particularly when paired with the bypassing of ACIP's review process for the new COVID vaccine policies. These changes create uncertainty about who can access vaccines. Without clear CDC recommendations, insurance companies may impose their own coverage criteria, potentially increasing costs for a vaccine that was previously free for most Americans. Healthcare providers, lacking federal guidance and ACIP's expertise, may struggle to advise patients, leading to a confusing and inequitable system that limits choice—hardly the 'medical freedom' Secretary Kennedy claims to champion. Ultimately, these actions threaten to erode trust in public health. FDA officials argue the new framework enhances transparency, yet bypassing ACIP's review and dismissing its members undermines that aim. Extensive data demonstrate that updated vaccines lower hospitalization and death rates, yet this evidence was sidelined. Such actions breed skepticism, making it harder to unite Americans around shared health goals. The stakes are high, but a better path is possible. Restoring trust requires transparent, evidence-based policymaking that prioritizes access to life-saving tools. I urge Secretary Kennedy and the administration to reconsider this framework, reinstate ACIP's role in vaccine policy, and ensure any new appointees are qualified, independent experts. If concerns about ACIP exist, they should be addressed through reform, not dissolution. Healthcare providers and community leaders must also educate patients about vaccination benefits, particularly for vulnerable groups like pregnant women and those with high exposure. Individuals can take action by staying informed, discussing vaccination with their doctors, and advocating for clear, equitable access to vaccines. By working together—government, providers, and citizens—we can protect lives, reduce the burden of Long COVID, and rebuild confidence in our public health system. We must seize this opportunity to unite around science and ensure a healthier, safer, and prosperous future for all Americans.